Literature DB >> 14738447

Qualitative and quantitative abnormalities in splenic dendritic cell populations in NOD mice.

A C Vasquez1, M Feili-Hariri, R J Tan, P A Morel.   

Abstract

The phenotype and function of splenic DC populations from diabetes-prone NOD mice were characterized and compared to DC from diabetes-resistant strains in the presence or absence of Flt3 ligand (FL) treatment. NOD mice were found to have significantly fewer CD8alpha+ DC than both B10.BR and C57BL/6 mice, and this defect was reversed by FL treatment. Freshly isolated CD8alpha+ and CD8alpha- DC from all three strains were found to express similar levels of costimulatory molecules and this was similar in both FL-treated and untreated animals. IL-12 p40 production was significantly lower in purified CD11c+ DC from NOD mice compared to DC from C57BL/6 or B10.BR mice. CD8alpha+ DC isolated from NOD mice produced lower levels of IL-12p40 than CD8alpha+ DC from C57CBL/6 and this was dependent on the nature of the stimulus given. In contrast both CD8alpha+ and CD8alpha- DC from FL-treated mice produced high levels of IL-12p40 following activation, but only the CD8alpha- DC produced IL-12p70. Functionally, freshly isolated CD8alpha- DC were more stimulatory than CD8alpha+ DC in a primary allogeneic mixed lymphocyte reaction. However, DC maturation resulted in increased T cell stimulatory capacity for both DC subsets, and this pattern was seen in all strains. These results demonstrate significant differences in phenotype and function of splenic NOD CD8alpha+ DC, and further suggest that FL treatment may reverse some of these abnormalities.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14738447      PMCID: PMC1808940          DOI: 10.1111/j.1365-2249.2003.02359.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  48 in total

1.  Identification and characterization of the antigen-specific subpopulation of alloreactive CD4+ T cells in vitro and in vivo.

Authors:  N R Krieger; C G Fathman; M K Shaw; W M Ridgway
Journal:  Transplantation       Date:  2000-02-27       Impact factor: 4.939

2.  MHC class II molecules transferred between allogeneic dendritic cells stimulate primary mixed leukocyte reactions.

Authors:  P Bedford; K Garner; S C Knight
Journal:  Int Immunol       Date:  1999-11       Impact factor: 4.823

3.  Development of CD8alpha-positive dendritic cells from a common myeloid progenitor.

Authors:  D Traver; K Akashi; M Manz; M Merad; T Miyamoto; E G Engleman; I L Weissman
Journal:  Science       Date:  2000-12-15       Impact factor: 47.728

4.  CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen.

Authors:  D Vremec; J Pooley; H Hochrein; L Wu; K Shortman
Journal:  J Immunol       Date:  2000-03-15       Impact factor: 5.422

5.  Aberrant macrophage cytokine production is a conserved feature among autoimmune-prone mouse strains: elevated interleukin (IL)-12 and an imbalance in tumor necrosis factor-alpha and IL-10 define a unique cytokine profile in macrophages from young nonobese diabetic mice.

Authors:  D G Alleva; R P Pavlovich; C Grant; S B Kaser; D I Beller
Journal:  Diabetes       Date:  2000-07       Impact factor: 9.461

6.  Phenotypic and functional characteristics of BM-derived DC from NOD and non-diabetes-prone strains.

Authors:  M Feili-Hariri; P A Morel
Journal:  Clin Immunol       Date:  2001-01       Impact factor: 3.969

7.  Low CD86 expression in the nonobese diabetic mouse results in the impairment of both T cell activation and CTLA-4 up-regulation.

Authors:  E Dahlén; G Hedlund; K Dawe
Journal:  J Immunol       Date:  2000-03-01       Impact factor: 5.422

8.  Differentiation of myeloid dendritic cells into CD8alpha-positive dendritic cells in vivo.

Authors:  M Merad; L Fong; J Bogenberger; E G Engleman
Journal:  Blood       Date:  2000-09-01       Impact factor: 22.113

9.  A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis.

Authors:  G Süss; K Shortman
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

10.  CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo.

Authors:  J M den Haan; S M Lehar; M J Bevan
Journal:  J Exp Med       Date:  2000-12-18       Impact factor: 14.307

View more
  30 in total

1.  Functional specialization of islet dendritic cell subsets.

Authors:  Na Yin; Jiangnan Xu; Florent Ginhoux; Gwendalyn J Randolph; Miriam Merad; Yaozhong Ding; Jonathan S Bromberg
Journal:  J Immunol       Date:  2012-04-16       Impact factor: 5.422

Review 2.  Dendritic cell immunotherapy for autoimmune diabetes.

Authors:  Maryam Feili-Hariri; Rafael R Flores; A Cecilia Vasquez; Penelope A Morel
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 3.  The natural killer T lymphocyte: a player in the complex regulation of autoimmune diabetes in non-obese diabetic mice.

Authors:  S L Cardell
Journal:  Clin Exp Immunol       Date:  2006-02       Impact factor: 4.330

Review 4.  Pathogenic mechanisms in type 1 diabetes: the islet is both target and driver of disease.

Authors:  Kate L Graham; Robyn M Sutherland; Stuart I Mannering; Yuxing Zhao; Jonathan Chee; Balasubramanian Krishnamurthy; Helen E Thomas; Andrew M Lew; Thomas W H Kay
Journal:  Rev Diabet Stud       Date:  2012-12-28

5.  T cell hyperactivity in lupus as a consequence of hyperstimulatory antigen-presenting cells.

Authors:  Jiankun Zhu; Xuebin Liu; Chun Xie; Mei Yan; Ying Yu; Eric S Sobel; Edward K Wakeland; Chandra Mohan
Journal:  J Clin Invest       Date:  2005-06-09       Impact factor: 14.808

Review 6.  Role of regulatory invariant CD1d-restricted natural killer T-cells in protection against type 1 diabetes.

Authors:  Shabbir Hussain; Melany Wagner; Dalam Ly; Terry L Delovitch
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

7.  Pre-existing autoimmunity determines type 1 diabetes outcome after Flt3-ligand treatment.

Authors:  Tom L Van Belle; Therese Juntti; Jeanette Liao; Matthias G von Herrath
Journal:  J Autoimmun       Date:  2009-12-09       Impact factor: 7.094

8.  NKG2D-RAE-1 receptor-ligand variation does not account for the NK cell defect in nonobese diabetic mice.

Authors:  Lisa M Maier; Sarah K Howlett; Kara M Rainbow; Jan Clark; Joanna M M Howson; John A Todd; Linda S Wicker
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

9.  Gene therapy for type 1 diabetes: a novel approach for targeted treatment of autoimmunity.

Authors:  Rémi J Creusot; C Garrison Fathman
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

10.  Rabbit polyclonal mouse antithymocyte globulin administration alters dendritic cell profile and function in NOD mice to suppress diabetogenic responses.

Authors:  Yanfei Huang; Matthew Parker; Changqing Xia; Ruihua Peng; Clive Wasserfall; Tracy Clarke; Lizhen Wu; Tayseer Chowdhry; Martha Campbell-Thompson; John Williams; Michael Clare-Salzler; Mark A Atkinson; Karl L Womer
Journal:  J Immunol       Date:  2009-04-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.